JAMA Neurology Author Interviews podcast

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

0:00
21:13
Recuar 15 segundos
Avançar 15 segundos

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

Mais episódios de "JAMA Neurology Author Interviews"